头体针联合玻璃酸钠眼液治疗中重度干眼症的临床研究
作者:
作者单位:

1.甘肃中医药大学第一临床医学院, 甘肃 兰州 730000;2.兰州市第一人民医院 眼科, 甘肃 兰州 730050;3.甘肃省人民医院 眼科, 甘肃 兰州 730013

通讯作者:

刘勤,E-mail:summliu@126.com;Tel:13909488929

中图分类号:

R777.34

基金项目:

甘肃省自然科学基金(No:23JRRA1460);兰州市科技计划项目(No:2023-ZD-131)


Clinical study of head and body acupuncture combined with sodium hyaluronate eye solution in the treatment of moderate and severe dry eye
Author:
Affiliation:

1.The First Clinical College of Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, China;2.Department of Ophthalmology, The First People's Hospital of Lanzhou, Gansu 730050, China;3.Department of Ophthalmology, Gansu Provincial People's Hospital, Lanzhou, Gansu 730013, China

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [30]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    目的 探讨头体针联合玻璃酸钠眼液治疗中重度干眼症的效果。方法 前瞻性选取2021年11月—2023年3月甘肃省人民医院收治的62例中重度干眼症患者,随机数表法分为研究组、对照组,各31例。对照组给予玻璃酸钠眼液治疗,研究组在对照组基础上给予头体针治疗,两组治疗4周观察效果。比较两组中医证候评分、眼部症状评分、泪膜稳定性相关指标、临床疗效、睑板腺分泌能力、泪液中细胞因子及不良反应情况。结果 研究组治疗前后主症、次症中医证候评分的差值均高于对照组(P <0.05)。研究组治疗前后眼表疾病指数、眼表荧光染色评分的差值均高于对照组(P <0.05)。研究组治疗前后泪眼分泌实验、泪河高度、非侵入性泪膜破裂时间、脂质层厚度的差值均高于对照组(P <0.05)。研究组总有效率高于对照组(P <0.05)。研究组睑板腺分泌能力高于对照组(P <0.05)。研究组治疗前后溶菌酶、表皮生长因子、乳铁蛋白的差值均高于对照组(P <0.05)。两组治疗期间无明显不良反应。结论 头体针联合玻璃酸钠眼液治疗中重度干眼症疗效显著,可明显改善患者眼部症状及泪膜稳定性相关指标,增强睑板腺分泌能力,促进溶菌酶、表皮生长因子、乳铁蛋白分泌,安全可靠。

    Abstract:

    Objective To investigate the effect of head and body acupuncture combined with sodium hyaluronate eye solution on moderate and severe dry eye.Methods Sixty-two patients with moderate and severe dry eye treated from November 2021 to March 2023 were prospectively selected and randomly divided into study group and control group, with 31 cases in each group. The control group was treated with sodium hyaluronate eye solution, and the study group was treated with head and body acupuncture on the basis of the control group. TCM syndrome score, ocular symptom score, relevant indexes of tear film stability, clinical efficacy, meibomian gland secretion capacity, tear cytokines and adverse reactions were compared between the two groups.Results The difference of TCM syndrome scores of primary and secondary symptoms in the study group before and after treatment was higher than that in the control group (P < 0.05). The difference of ocular surface disease index and ocular surface fluorescence score before and after treatment in the study group were higher than those in the control group (P < 0.05). The differences of lacrimal secretion test, lacrimal river height, non-invasive tear film rupture time and lipid layer thickness before and after treatment in the study group were higher than those in the control group (P < 0.05). The total effective rate of the study group was higher than that of the control group (P < 0.05). The secretion capacity of meibomian gland in the study group was higher than that in the control group (P < 0.05). The differences of lysozyme, epidermal growth factor and lactoferrin in the study group before and after treatment were higher than those in the control group (P < 0.05). There were no obvious adverse reactions in the two groups during treatment.Conclusion Head and body acupuncture combined with sodium hyaluronate eye solution is effective in the treatment of moderate and severe dry eye, which can significantly improve ocular symptoms and related indexes of tear film stability, enhance the secretion capacity of meibomian gland, and promote the secretion of lysozyme, epidermal growth factor and lactoferrin, which is safe and reliable.

    参考文献
    [1] HAKIM F E, FAROOQ A V. Dry eye disease: an update in 2022[J]. JAMA, 2022, 327(5): 478-479.
    [2] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:定义和分类(2020年)[J]. 中华眼科杂志, 2020, 56(6): 418-422.
    [3] HYNNEKLEIV L, MAGNO M, VERNHARDSDOTTIR R R, et al. Hyaluronic acid in the treatment of dry eye disease[J]. Acta Ophthalmol, 2022, 100(8): 844-860.
    [4] 刘萱, 杜娟, 董永孝, 等. 除风益损汤联合妥布霉素地塞米松眼液、玻璃酸钠滴眼液治疗白内障干眼症效果观察[J]. 海南医学, 2022, 33(24): 3218-3221.
    [5] 杨钊, 何文静, 李凤媚, 等. 氟米龙滴眼液联合玻璃酸钠滴眼液治疗干燥综合征型干眼患者的临床疗效[J]. 广西医学, 2022, 44(14): 1569-1573.
    [6] LABETOULLE M, BENITEZ-DEL-CASTILLO J M, BARABINO S, et al. Artificial tears: biological role of their ingredients in the management of dry eye disease[J]. Int J Mol Sci, 2022, 23(5): 2434-2437.
    [7] 王莎莎, 王晶, 李延萍. 中医辨治干眼症探讨[J]. 河南中医, 2021, 41(3): 392-395.
    [8] 孙榕, 回世洋. 玻璃酸钠联合针灸治疗干眼症的疗效及对患者炎症因子水平的影响[J]. 西部中医药, 2022, 35(5): 132-135.
    [9] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:检查和诊断(2020年)[J]. 中华眼科杂志, 2020, 56(10): 741-747.
    [10] 李传课. 中医眼科学[M]. 第2版. 北京: 人民卫生出版社, 2011: 432-439.
    [11] SCHIFFMAN R M, CHRISTIANSON M D, JACOBSEN G, et al. Reliability and validity of the ocular surface disease index[J]. Arch Ophthalmol, 2000, 118(5): 615-621.
    [12] 李勇, 杜婧, 李晶, 等. 不同频率强脉冲光联合睑板腺按摩治疗睑板腺功能障碍导致的干眼症患者的临床疗效[J]. 眼科新进展, 2020, 40(12): 1152-1156.
    [13] 国家中医药管理局. 中医病证诊断疗效标准[S]. 南京: 南京大学出版社, 1994: 101-102.
    [14] 陈剑英, 胡欣欣, 王盛展, 等. 广角激光扫描检眼镜用于眼全科门诊近视患者周边视网膜病变筛查的研究[J]. 中华全科医学, 2022, 20(11): 1820-1823.
    [15] 刘红, 滕月, 俞晓艺, 等. 岭南火针联合0.1%玻璃酸钠滴眼液治疗干眼症的随机对照研究[J]. 针刺研究, 2021, 46(10): 863-868.
    [16] SALIM S, KAMATH S J, JEGANATHAN S, et al. Comparing the efficacy of sodium hyaluronate eye drops and carboxymethylcellulose eye drops in treating mild to moderate dry eye disease[J]. Indian J Ophthalmol, 2023, 71(4): 1593-1597.
    [17] 孙远征, 陈存阳, 于天洋, 等. 调神法针刺治疗肝肾阴虚型干眼症临床观察[J]. 中国针灸, 2022, 42(2): 162-166.
    [18] CHAN V W Y, PHAN C M, NGO W, et al. Lysozyme deposition on contact lenses in an in vitro blink-simulation eye model versus a static vial deposition model[J]. Eye Contact Lens, 2021, 47(7): 388-393.
    [19] BERRA M, GALPERíN G, BERRA F, et al. Tear lysozyme in Sj?gren′s syndrome, meibomian gland dysfunction, and non-dry-eye[J]. Arq Bras Oftalmol, 2021, 85(2): 103-108.
    [20] LEE D, SONG S, CHO G, et al. Elucidating the molecular interactions between lipids and lysozyme: evaporation resistance and bacterial barriers for dry eye disease[J]. Nano Lett, 2023, 23(20): 9451-9460.
    [21] SUGIMURA T, SEO T, TERASAKI N, et al. Efficacy and safety of breast milk eye drops in infants with eye discharge[J]. Acta Paediatr, 2021, 110(4): 1322-1329.
    [22] 朱佳丽, 李卫红. 重组人表皮生长因子联合氟米龙滴眼液对儿童干眼症临床效果、眼表功能和生活质量的影响[J]. 贵州医药, 2022, 46(12): 1938-1939.
    [23] PETERSON J L, CERESA B P. Epidermal growth factor receptor expression in the corneal epithelium[J]. Cells, 2021, 10(9): 2409-2413.
    [24] 王晓杰, 惠琦, 金子, 等. 细胞因子类药物在眼科临床的应用进展[J]. 浙江大学学报(医学版), 2022, 51(5): 626-633.
    [25] 赵强, 孙墩坡, 滕光红, 等. 杞菊地黄丸联合重组人表皮生长因子滴眼液治疗白内障术后干眼症的疗效分析[J]. 中国现代医学杂志, 2021, 31(24): 84-88.
    [26] SINGH J, SHARMA M, JAIN N, et al. Lactoferrin and its nano-formulations in rare eye diseases[J]. Indian J Ophthalmol, 2022, 70(7): 2328-2334.
    [27] CONNELL S, KAWASHIMA M, NAKAMURA S, et al. Lactoferrin ameliorates dry eye disease potentially through enhancement of short-chain fatty acid production by gut microbiota in mice[J]. Int J Mol Sci, 2021, 22(22): 12384-12387.
    [28] 孟繁娟, 孙冬, 李朝辉, 等. 血浆炎症细胞因子及乳铁蛋白含量表达与干眼症相关性分析[J]. 中国老年学杂志, 2016, 36(19): 4860-4861.
    [29] REGUEIRO U, LóPEZ-LóPEZ M, VARELA-FERNáNDEZ R, et al. Biomedical applications of lactoferrin on the ocular surface[J]. Pharmaceutics, 2023, 15(3): 865-868.
    [30] 陈耀华, 顾佩霞. 杞菊地黄丸联合玻璃酸钠滴眼液治疗干眼症的效果分析[J]. 中国现代医学杂志, 2023, 33(6): 61-64.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

郝红艳,赵瑜,杨侃,何霞飞,杨继若,汤志刚,卢荣,刘勤.头体针联合玻璃酸钠眼液治疗中重度干眼症的临床研究[J].中国现代医学杂志,2024,34(11):1-7

复制
分享
文章指标
  • 点击次数:461
  • 下载次数: 439
  • HTML阅读次数: 67
  • 引用次数: 0
历史
  • 收稿日期:2023-10-24
  • 在线发布日期: 2024-12-19
文章二维码